Azra Ligon

Chief, Clinical Cytogenetics · Brigham and women's Hospital · company speakers →

I am an ABMGG-certified Clinical Cytogeneticist interested in both inherited and acquired cytogenetic abnormalities. My research background includes identification of key genes involved in abnormal human development. I also contributed to several landmark studies in cancer genetics and among these is identification of the tumor suppressor gene, PTEN. I have studied genomic changes in both pediatric and adult primary CNS tumors and also contributed to the analysis of key genomic changes in lymphoma. I led the successful translation of basic research findings into clinical tests offered through the Brigham & Women's Hospital (BWH) Center for Advanced Molecular Diagnostics. Locally, I served as an ABMGG laboratory fellowship Program Director for 20 years, while also participating in several local, regional, and national courses focused on the genetics of disease. Nationally, I have been active on ACMG and APHMG Committees and served for several cycles as an item writer and then Clinical Cytogenetics Examination Book Chief. I was elected to the ABMGG Board of Directors, with which I completed a two-year term as Chair. Finally, I was a member of the ACGME Milestones Committee and the Medical Genetics and Genomics Review Committee. Currently, I am the Chief of Clinical Cytogenetics at BWH and, in January 2025, began work as the CEO of the American Board of Medical Genetics and Genomics.

Is this you? Claim this profile →